We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

BioPerfectus Technologies

Bioperfectus Technologies Co., Ltd. is one of the leading molecular diagnostic solution providers in the global in-vi... read more Featured Products: More products

Download Mobile App





Bioperfectus Showcases Its Molecular Diagnostic Products for Infectious Diseases at MEDLAB 2022 Online

By LabMedica International staff writers
Posted on 25 Jan 2022
Print article
Image: STC-96A Real-Time PCR System (Photo courtesy of Bioperfectus)
Image: STC-96A Real-Time PCR System (Photo courtesy of Bioperfectus)

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) presented its molecular diagnostic products for various infectious diseases at MEDLAB 2022 Online from January 5 to February 28, 2022.

Bioperfectus used its virtual booth to exhibit the STC-96A Real-Time PCR system and STC-96A Plus Real-Time PCR system that are more-than-ever flexible, efficient and reliable breakthrough in the real-time PCR analysis of gene expression and genetic variation. The temperature uniformity of the STC-96A Plus and STC-96A Plus across 96 wells is within a remarkable 0.1℃, which meets all needs for highly precise diagnostic and study use, including High-Resolution Melting Curve (HRM) applications

Bioperfectus also highlighted its COVID-19 testing solutions, including the COVID-19 Coronavirus Real Time PCR Kit, an In Vitro Diagnostic (IVD) reagent using fluorescent PCR technology to qualitatively detect Open Reading Frame gene region (ORF1a/b) and viral nucleocapsid region (N) of SARS-CoV-2 RNA from upper and lower respiratory tract specimens. In addition, the company presented the Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit, including Prepacked Extraction Tube, which is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in nasopharyngeal swabs from individuals who are suspected of COVID-19 within the first seven days of the onset of symptoms.

Visitors exploring its online booth also viewed the Nucleic Acid Extraction Solutions produced by Bioperfectus that offer a comprehensive PCR laboratory solution, including SSNP series Nucleic Acid Extraction System (3000A, 2000B & 9600A), Nucleic Acid Extraction Rapid Kit (Magnetic Bead Method) as well as Viral Nucleic Acid Isolation Kit (Silica-Based Spin Column), which integrates new technologies such as machine, electricity and computer software to enable automatic nucleic acid extraction in one time.

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd.

New
Gold Member
Chagas Disease Test
CHAGAS Cassette
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
Treponema Pallidum Test
ZEUS IFA Fluorescent Treponemal Antibody-Absorption (FTA-ABS) Test System
New
Auto 5-Part Differential Analyzer
XR-1000 Pure

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.